Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07295717 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate ALN-4285 in Adult Healthy Volunteers

Name: A Study to Evaluate ALN-4285 in Adult Healthy Volunteers — clinical trial record (NCT07295717)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorAlnylam Pharmaceuticals

Started2025-12-12

View on ClinicalTrials.gov ↗

Amendment history

2026-08-11

6 amendments v2-v7

6 re-verifications since 2026-03-30, no change to tracked fields

2026-02-26

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Study sitesdetails revised at 1 of 1 site

2025-12-10

Original filing

Alnylam Pharmaceuticals

31 trials monitored

See 5 trials at risk

The purpose of this study is to: * evaluate the safety and tolerability of single ascending doses of ALN-4285 in healthy volunteers * characterize the single-dose pharmacokinetics (PK) of ALN-4285

Trial Details

NCT Number	NCT07295717
Lead Sponsor	Alnylam Pharmaceuticals
Conditions	Healthy Volunteers
Enrollment	76 participants
Start Date	2025-12-12
Primary Completion	2026-12-29 (estimated)
Study Completion	2027-03-23 (estimated)
Updated on ClinicalTrials.gov	2026-09-16